regulation of biopharmaceuticals in canada environmental research envr 401 supervisor george mccourt...
DESCRIPTION
Group Members Ashleigh Akalehiywot April Aliermo Mara Dacso Lillian Harris Andrea Hicks Ted Walker Kate WashingtonTRANSCRIPT
![Page 1: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/1.jpg)
Regulation of Regulation of Biopharmaceuticals in CanadaBiopharmaceuticals in Canada
Environmental ResearchEnvironmental ResearchENVR 401ENVR 401
Supervisor George McCourtSupervisor George McCourtOct. 16, 2003Oct. 16, 2003
![Page 2: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/2.jpg)
Presentation OutlinePresentation Outline
Client backgroundClient background Context of ResearchContext of Research Research QuestionResearch Question MethodologyMethodology Expected ResultsExpected Results Data SourcesData Sources Possible ProblemsPossible Problems
![Page 3: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/3.jpg)
Group MembersGroup Members
Ashleigh AkalehiywotAshleigh Akalehiywot April AliermoApril Aliermo Mara DacsoMara Dacso Lillian HarrisLillian Harris Andrea HicksAndrea Hicks Ted WalkerTed Walker Kate WashingtonKate Washington
![Page 4: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/4.jpg)
RegulationRegulation
BiopharmaceuticalsBiopharmaceuticals
Environmental RiskEnvironmental Risk
![Page 5: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/5.jpg)
Polaris Institute ~ Ottawa, Polaris Institute ~ Ottawa, CanadaCanada
"enable citizen movements to re-skill "enable citizen movements to re-skill and re-tool themselves to fight for and re-tool themselves to fight for democratic social change" democratic social change"
Challenges public policy makingChallenges public policy making
www.polarisinstitute.orgwww.polarisinstitute.org
![Page 6: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/6.jpg)
Biojustice Project ~ Lucy SharrattBiojustice Project ~ Lucy Sharratt
Concerned with the power of large Concerned with the power of large corporations to push genetically corporations to push genetically engineered products and industries.engineered products and industries.
Aims to provide information and Aims to provide information and resources to grass-roots anti-biotech resources to grass-roots anti-biotech activists.activists.
![Page 7: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/7.jpg)
Biojustice Project – Our RoleBiojustice Project – Our Role
To fill in the gaps within research and To fill in the gaps within research and regulation of plant molecular farming regulation of plant molecular farming (biopharmaceuticals)(biopharmaceuticals)
To provide a framework on which the To provide a framework on which the institute can use to influence regulationinstitute can use to influence regulation
![Page 8: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/8.jpg)
Context of ResearchContext of Research
1980’s advances in biotechnology1980’s advances in biotechnology 1990’s introduction of regulations1990’s introduction of regulations Regulatory Directive Dir2000-07: Guidelines for Regulatory Directive Dir2000-07: Guidelines for
the Environmental Release of Plants with Novel the Environmental Release of Plants with Novel Traits within Confined Field Trials in CanadaTraits within Confined Field Trials in Canada
![Page 9: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/9.jpg)
Context of ResearchContext of Research Three governing bodies:Three governing bodies:
Canadian Food Inspection Agency (CFIA) Canadian Food Inspection Agency (CFIA) Health Canada (HC)Health Canada (HC)Environment Canada (EC)Environment Canada (EC)
"used existing acts to incorporate new "used existing acts to incorporate new regulations or amend existing ones in regulations or amend existing ones in order to deal with GM foods" (CBAC, order to deal with GM foods" (CBAC, 2002)2002)
![Page 10: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/10.jpg)
Context of ResearchContext of Research
Royal Society of Canada ReportRoyal Society of Canada ReportElements of Precaution: Recommendations for Elements of Precaution: Recommendations for the Regulation of Food Biotechnology in the Regulation of Food Biotechnology in Canada (2001)Canada (2001)
Commissioned by CFIA, HC, and ECCommissioned by CFIA, HC, and EC 53 recommendations53 recommendations
![Page 11: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/11.jpg)
Context of ResearchContext of Research
Government Response to RSCGovernment Response to RSCReportReport
Action Plans - November 23, 2001Action Plans - November 23, 2001 4 updates since, most recent in June 4 updates since, most recent in June
20032003
![Page 12: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/12.jpg)
Context of ResearchContext of Research
Interim Amendment to Dir2000-07 for Interim Amendment to Dir2000-07 for Confined Research Field Trials of PNT's Confined Research Field Trials of PNT's for Plant Molecular Farmingfor Plant Molecular Farming
April 22, 2003April 22, 2003
![Page 13: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/13.jpg)
Directives(Pre-2001)
InterimAmendments
(2003)
RSC(2001)
ActionPlans(2001)
OriginalLegislation
(1980’s)
![Page 14: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/14.jpg)
Research QuestionResearch Question
To what extent do the Interim To what extent do the Interim Amendments on field testing of Amendments on field testing of Plant Molecular Farming address Plant Molecular Farming address the environmental concerns raised the environmental concerns raised in the RSC report?in the RSC report?
![Page 15: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/15.jpg)
Research QuestionResearch Question
Motivations for creating the amendments?Motivations for creating the amendments? Time-line for solidifying the amendments as Time-line for solidifying the amendments as
regulation?regulation? Effectiveness of the amendments in Effectiveness of the amendments in
addressing environmental risk?addressing environmental risk?
![Page 16: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/16.jpg)
Directives(Pre-2001)
InterimAmendments
(2003)
RSC(2001)
ActionPlans(2001)
OriginalLegislation
(1980’s)
![Page 17: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/17.jpg)
MethodologyMethodologyExtended Literature ReviewExtended Literature Review
Extensive analysis of government Extensive analysis of government regulations, documents, conference regulations, documents, conference paperspapers
To determine sources of information and To determine sources of information and reasoning behind the amendmentsreasoning behind the amendments
![Page 18: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/18.jpg)
MethodologyMethodologyCase StudiesCase Studies
Comparison between the European Union, the Comparison between the European Union, the United States and CanadaUnited States and Canada
Determine how each regulates Plant Molecular Determine how each regulates Plant Molecular FarmingFarming
Compare effectivenessCompare effectiveness
![Page 19: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/19.jpg)
MethodologyMethodologyInterviewsInterviews
Interviews with government officialsInterviews with government officials
To determine the progress of solidifying To determine the progress of solidifying the amendments and phase currently the amendments and phase currently underwayunderway
![Page 20: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/20.jpg)
MethodologyMethodology
Comparison of the amendments with Comparison of the amendments with scientific data and the RSC report scientific data and the RSC report
Determine the extent to which Determine the extent to which environmental risk is addressed in the environmental risk is addressed in the amendmentsamendments
![Page 21: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/21.jpg)
Expected ResultsExpected Results
Identify gaps in Canada's regulatory Identify gaps in Canada's regulatory systemsystem
Provide Polaris Institute with a Provide Polaris Institute with a framework for further work with the framework for further work with the government and the public concerning government and the public concerning regulationregulation
![Page 22: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/22.jpg)
Data SourcesData Sources
Primary sources (interview)Primary sources (interview) Published scientific researchPublished scientific research Published reviews of current research Published reviews of current research
and regulation (RSC report)and regulation (RSC report) Government documents from Canada, Government documents from Canada,
US, and the EUUS, and the EU
![Page 23: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/23.jpg)
Time LineTime LineWeeks 1 & 2 establish baseline data for Canada & contact potential intervieweesWeek 3 begin case study research (EU &US)
Week 4 compile/analyze/compare findings
Week 5 design framework for final report
Week 6 prepare for presentation
Week 7 presentation & finish report
![Page 24: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/24.jpg)
Division of LabourDivision of Labour
Administrative TasksAdministrative Tasks Liaison with Lucy (Mara)Liaison with Lucy (Mara) Liaison with Field Study Group (Lillian)Liaison with Field Study Group (Lillian) Research Paper editors (April, Kate)Research Paper editors (April, Kate) PowerPoint presentation (Ted, Ashleigh)PowerPoint presentation (Ted, Ashleigh) Final Oral (Andrea, Kate)Final Oral (Andrea, Kate) Website (Ted, April)Website (Ted, April)
![Page 25: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/25.jpg)
Division of LabourDivision of Labour
Research Tasks Research Tasks EU Case Study (Lillian, Kate)EU Case Study (Lillian, Kate) US Case Study (Mara, Ashleigh)US Case Study (Mara, Ashleigh) Government contact interview (April)Government contact interview (April) RSC expert (Andrea)RSC expert (Andrea) Action Plan expert (Ted)Action Plan expert (Ted) Canadian Regulation experts (everyone)Canadian Regulation experts (everyone)
![Page 26: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/26.jpg)
Possible ProblemsPossible Problems
Addressing client's needsAddressing client's needs Focusing scope of research to a Focusing scope of research to a
manageable areamanageable area Accessing sufficient informationAccessing sufficient information Accessing relevant informationAccessing relevant information
![Page 27: Regulation of Biopharmaceuticals in Canada Environmental Research ENVR 401 Supervisor George McCourt Oct. 16, 2003](https://reader033.vdocument.in/reader033/viewer/2022051301/5a4d1adf7f8b9ab0599767ac/html5/thumbnails/27.jpg)
In a nutshell…In a nutshell…
Determine effectiveness of Canada's Determine effectiveness of Canada's regulatory system for the field testing of regulatory system for the field testing of biopharmaceuticals.biopharmaceuticals.